Perianal fistulising Crohn's disease: utilising the TOpClass classification in clinical practice to provide targeted individualised care.

Crohn’s disease multi-disciplinary management perianal fistula

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
10 Aug 2024
Historique:
received: 08 02 2024
revised: 26 04 2024
accepted: 11 06 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 12 8 2024
Statut: aheadofprint

Résumé

Perianal fistulation is a challenging phenotype of Crohn's disease with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalised, with lack of attention to the clinical heterogenicity seen. The recent 'TOpClass classification system' for perianal fistulising Crohn's disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals. In this article, we discuss the clinical applicability of the TOpClass model and provide direction on its use in clinical practice. An international group of perianal clinicians participated in an expert consensus to define how the TOpClass system can be incorporated into real-life practice. This included gastroenterologists, IBD surgeons, and radiologists specialised in PFCD. The process was informed by the multi-disciplinary team management of eight high-volume fistula centres in North America, Europe, and Australia. The process produced position statements to accompany the classification system and guide PFCD management. The statements range from the management of patients with quiescent perianal disease to those with severe PFCD requiring diverting-ostomy and/or proctectomy. The optimisation of medical therapies, as well as the use of surgery, in fistula closure and symptom management is explored across each classification group. This article provides an overview of the system's use in clinical practice. It aims to enable clinicians to have a pragmatic and patient-goal centred approach to medical and surgical management options for individual patients with PFCD.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Perianal fistulation is a challenging phenotype of Crohn's disease with significant impact on quality of life. Historically, fistulae have been classified anatomically in relation to the sphincter complex, and management guidelines have been generalised, with lack of attention to the clinical heterogenicity seen. The recent 'TOpClass classification system' for perianal fistulising Crohn's disease (PFCD) addresses this issue, and classifies patients into defined groups, which provide a focus for fistula management that aligns with disease characteristics and patient goals. In this article, we discuss the clinical applicability of the TOpClass model and provide direction on its use in clinical practice.
METHODS METHODS
An international group of perianal clinicians participated in an expert consensus to define how the TOpClass system can be incorporated into real-life practice. This included gastroenterologists, IBD surgeons, and radiologists specialised in PFCD. The process was informed by the multi-disciplinary team management of eight high-volume fistula centres in North America, Europe, and Australia.
RESULTS RESULTS
The process produced position statements to accompany the classification system and guide PFCD management. The statements range from the management of patients with quiescent perianal disease to those with severe PFCD requiring diverting-ostomy and/or proctectomy. The optimisation of medical therapies, as well as the use of surgery, in fistula closure and symptom management is explored across each classification group.
CONCLUSION CONCLUSIONS
This article provides an overview of the system's use in clinical practice. It aims to enable clinicians to have a pragmatic and patient-goal centred approach to medical and surgical management options for individual patients with PFCD.

Identifiants

pubmed: 39134293
pii: S1542-3565(24)00692-X
doi: 10.1016/j.cgh.2024.06.047
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Luke N Hanna (LN)

St. Mark's Hospital, Gastroenterology, London, United Kingdom. Electronic address: Luke.hanna2@nhs.net.

Sulak Anandabaskaran (S)

School of Clinical Medicine- St Vincent's Healthcare Clinical Campus- University of New South Wales, Gastroenterology, Sydney, Australia.

Nusrat Iqbal (N)

St. Mark's Hospital, Colorectal Surgery, London, United Kingdom.

Jeroen Geldof (J)

University Hospital Ghent, Gastroenterology, Ghent, Belgium.

Jean-Frédéric LeBlanc (JF)

Hôpital du Sacré-Coeur de Montréal, Gastroenterology, Montreal, Canada.

Anders Dige (A)

Aarhus University Hospital, Gastroenterology, Aarhus, Denmark.

Lilli Lundby (L)

Aarhus University Hospital, Colorectal Surgery, Aarhus, Denmark.

Séverine Vermeire (S)

University Hospitals of Leuven, Gastroenterology, Leuven, Belgium.

André D'Hoore (A)

University Hospitals of Leuven, Colorectal Surgery, Leuven, Belgium.

Bram Verstockt (B)

University Hospitals of Leuven, Gastroenterology, Leuven, Belgium.

Gabriele Bislenghi (G)

University Hospitals of Leuven, Colorectal Surgery, Leuven, Belgium.

Danny De Looze (D)

University Hospital Ghent, Gastroenterology, Ghent, Belgium.

Triana Lobaton (T)

University Hospital Ghent, Gastroenterology, Ghent, Belgium.

Dirk Van de Putte (D)

University Hospital Ghent, Colorectal Surgery, Ghent, Belgium.

Antonino Spinelli (A)

Humanitas Research Hospital, Colorectal Surgery, Milan, Italy.

Michele Carvello (M)

Humanitas Research Hospital, Colorectal Surgery, Milan, Italy.

Silvio Danese (S)

IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.

Christianne J Buskens (CJ)

Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands.

Krisztina Gecse (K)

Amsterdam UMC- location AMC, Gastroenterology, Amsterdam, The Netherlands.

Roel Hompes (R)

Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands.

Marte Becker (M)

Amsterdam UMC- location AMC, Gastroenterology, Amsterdam, The Netherlands.

Jarmila van der Bilt (J)

Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands.

Wilhelmus Bemelman (W)

Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands.

Shaji Sebastian (S)

Hull University Teaching Hospitals, Gastroenterology, Hull, United Kingdom.

Gordan Moran (G)

Nottingham University Hospitals, Gastroenterology, Nottingham, United Kingdom.

Amy L Lightner (AL)

Scripps Clinic, Colorectal Surgery, San Diego, United States.

Serre-Yu Wong (SY)

Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States.

Jean-Frédéric Colombel (JF)

Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States.

Benjamin L Cohen (BL)

Cleveland Clinic, Gastroenterology, Ohio, United States.

Stefan Holubar (S)

Cleveland Clinic, Colorectal Surgery, Ohio, United States.

Nik S Ding (NS)

St. Vincent's Hospital, Gastroenterology, Melbourne, Australia.

Cori Behrenbruch (C)

St. Vincent's Hospital, Colorectal Surgery, Melbourne, Australia.

Kapil Sahnan (K)

St. Mark's Hospital, Colorectal Surgery, London, United Kingdom.

Ravi Misra (R)

St. Mark's Hospital, Gastroenterology, London, United Kingdom.

Phillip Lung (P)

St. Mark's Hospital, Radiology, London, United Kingdom.

Ailsa Hart (A)

St. Mark's Hospital, Gastroenterology, London, United Kingdom.

Phil Tozer (P)

St. Mark's Hospital, Colorectal Surgery, London, United Kingdom.

Classifications MeSH